Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.

Article Details

Citation

De Laurenzi V, Rogers GR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, Markova N, Rizzo WB

Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.

Nat Genet. 1996 Jan;12(1):52-7.

PubMed ID
8528251 [ View in PubMed
]
Abstract

Sjogren-Larsson syndrome (SLS) is an inherited neurocutaneous disorder characterized by mental retardation, spasticity and ichthyosis. SLS patients have a profound deficiency in fatty aldehyde dehydrogenase (FALDH) activity. We have now cloned the human FALDH cDNA and show that it maps to the SLS locus on chromosome 17p11.2. Sequence analysis of FALDH amplified from fibroblast mRNA and genomic DNA from 3 unrelated SLS patients reveals distinct mutations, including deletions, an insertion and a point mutation. The cloning of FALDH and the identification of mutations in SLS patients opens up possibilities for developing therapeutic approaches to ameliorate the neurologic and cutaneous symptoms of the disease.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Fatty aldehyde dehydrogenaseP51648Details